ÂÜÀòÂÒÂ×

Barbara Withers serves as Vice President of Clinical and Regulatory Strategy at Ocuphire. Dr. Withers has over 20 years in the pharmaceutical industry in various roles supporting drug development programs, spanning phases 1 through 4. Most recently, Dr. Withers held the position of Vice President of Clinical Operations at Aerpio Pharmaceuticals responsible for the oversight and delivery of clinical trials evaluating novel small molecules for the treatment of diabetic retinopathy, wet AMD, DME, glaucoma and COVID-19. Dr. Withers has previously held positions of Medical Writer supporting multiple NDAs, Drug Development Project Manager, Clinical Scientist and Safety Risk Management Leader at Pfizer; Clinical Scientist at GE Healthcare; and Site Head and Project Director at United Biosource Corporation. Dr. Withers received her B.S. in Biology from the University of Michigan and earned her Ph.D. in Molecular Biology and Genetics from Wayne State University School of Medicine and performed post-doctoral research in cancer biology at Parke Davis/Warner Lambert.